Laser treatment for Wrinkles
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine which treatment better reduces wrinkles around the eyes: a special type of laser or focused ultrasound. The laser option uses tiny beams to improve skin texture and reduce signs of aging, while the ultrasound option employs sound waves to tighten the skin without surgery. Suitable candidates for this trial are individuals aged 35 to 60 with noticeable wrinkles around their eyes and lighter skin tones (Fitzpatrick skin type I-III). As an Early Phase 1 trial, this research focuses on understanding how these treatments work in people, offering participants the opportunity to be among the first to experience these innovative options.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. However, it does exclude those who have used certain facial treatments recently, so it's best to discuss your specific medications with the trial team.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that fractional photothermolysis, a type of laser treatment, is generally well-tolerated. Studies indicate that this treatment causes only minor and short-lived side effects, such as skin redness or swelling, which resolve quickly. It is considered safe, particularly for treating sun-damaged skin and wrinkles.
High-intensity focused ultrasound treatment also has FDA approval for tightening skin around the eyes. Research shows it works by heating the skin, which can help tighten it. The side effects resemble those of other skin treatments, like temporary redness or swelling.
Overall, both treatments are generally safe with few long-lasting side effects.12345Why are researchers excited about this trial's treatments?
Fractional photothermolysis is unique because it uses a 1550-nm laser to safely and non-surgically improve facial wrinkles, photodamage, and scarring. This method stands out from standard treatments like topical retinoids or invasive procedures because it offers precision by targeting damaged skin areas without affecting surrounding tissue. High-intensity focused ultrasound, meanwhile, uses ultrasound waves to tighten tissues without surgery, making it a compelling alternative to more invasive options like facelifts. Researchers are excited about these treatments because they provide effective, non-invasive ways to address skin aging with minimal downtime, offering new hope for those seeking to rejuvenate their appearance.
What evidence suggests that this trial's treatments could be effective for wrinkles?
In this trial, participants will receive either fractional photothermolysis or high-intensity focused ultrasound as separate treatment options. In a previous study, dermatologists observed a 60% to 70% improvement in wrinkles around the eyes after using fractional photothermolysis, with this improvement lasting over time. Research has shown that this laser method can safely reduce wrinkles and skin damage by boosting collagen, which helps tighten the skin. High-intensity focused ultrasound, another treatment in this trial, uses sound waves to heat and tighten the skin, working similarly to some laser treatments. Both methods have received FDA approval for similar skin treatments and show promise in effectively reducing wrinkles.15678
Who Is on the Research Team?
Murad Alam, MD
Principal Investigator
Northwestern University
Are You a Good Fit for This Trial?
This trial is for men and women aged 35-60 with moderate wrinkles around the eyes, who have skin types I-III according to the Fitzpatrick scale. Participants must understand and consent to the study's procedures. Excluded are pregnant or breastfeeding individuals, those with certain medication histories, allergies to local anesthetics, recent facial treatments, abnormal scarring tendencies, eyelid disfigurements or significant skin diseases.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either 1550nm-fractionated laser treatment or micro-focused ultrasound treatment on periorbital wrinkles every 6-8 weeks for a total of 2 treatments
Follow-up
Participants are monitored for safety and effectiveness after treatment, including evaluation of adverse events and subject satisfaction
Long-term Follow-up
Participants are monitored for adverse events and subject satisfaction over a long-term period
What Are the Treatments Tested in This Trial?
Interventions
- Laser treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor